Net Income (Loss) Attributable to Parent in USD of BIORA THERAPEUTICS, INC. from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BIORA THERAPEUTICS, INC. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2019 to Q3 2024.
  • BIORA THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was -$18,402,000.000, a 74.9% increase year-over-year.
  • BIORA THERAPEUTICS, INC. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$31,539,000.000, a 74.2% increase year-over-year.
  • BIORA THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2023 was -$124,115,000.000, a 225% decline from 2022.
  • BIORA THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2022 was -$38,157,000.000, a 84.6% increase from 2021.
  • BIORA THERAPEUTICS, INC. annual Net Income (Loss) Attributable to Parent for 2021 was -$247,412,000.000, a 28.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

BIORA THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$31,539,000 -$18,402,000 +$55,052,000 +74.9% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 -$86,591,000 $6,465,000 +$24,272,000 01 Apr 2024 30 Jun 2024 10-Q 14 Nov 2024
Q1 2024 -$110,863,000 -$4,189,000 +$13,252,000 +76% 01 Jan 2024 31 Mar 2024 10-Q 14 Nov 2024
Q4 2023 -$124,115,000 -$15,413,000 -$1,691,000 -12.3% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2024
Q3 2023 -$122,424,000 -$73,454,000 -$68,340,000 -13.4% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$54,084,000 -$17,807,000 -$12,294,000 -2.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Nov 2024
Q1 2023 -$41,790,000 -$17,441,000 -$3,633,000 -26.3% 01 Jan 2023 31 Mar 2023 10-Q 14 Nov 2024
Q4 2022 -$38,157,000 -$13,722,000 +$79,152,000 +85.2% 01 Oct 2022 31 Dec 2022 10-K 30 Mar 2023
Q3 2022 -$117,309,000 -$5,114,000 +$38,630,000 +88.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$155,939,000 -$5,513,000 +$73,018,000 +93% 01 Apr 2022 30 Jun 2022 10-Q 13 Nov 2023
Q1 2022 -$228,957,000 -$13,808,000 +$18,455,000 +57.2% 01 Jan 2022 31 Mar 2022 10-Q 13 Nov 2023
Q4 2021 -$247,412,000 -$92,874,000 -$17,346,000 -23% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$230,066,000 -$43,744,000 +$3,321,000 +7.1% 01 Jul 2021 30 Sep 2021 10-K 30 Mar 2023
Q2 2021 -$233,387,000 -$78,531,000 -$25,748,000 -48.8% 01 Apr 2021 30 Jun 2021 10-K 30 Mar 2023
Q1 2021 -$207,639,000 -$32,263,000 -$15,111,000 -88.1% 01 Jan 2021 31 Mar 2021 10-K 30 Mar 2023
Q4 2020 -$192,528,000 -$75,528,000 -$25,052,000 -49.6% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2022
Q3 2020 -$167,476,000 -$47,065,000 +$10,068,000 +17.6% 01 Jul 2020 30 Sep 2020 10-K 28 Mar 2022
Q2 2020 -$177,544,000 -$52,783,000 -$36,374,000 -2.2% 01 Apr 2020 30 Jun 2020 10-K 28 Mar 2022
Q1 2020 -$141,170,000 -$17,152,000 +$6,867,000 +28.6% 01 Jan 2020 31 Mar 2020 10-K 28 Mar 2022
Q4 2019 -$148,037,000 -$50,476,000 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 -$57,133,000 01 Jul 2019 30 Sep 2019 10-K 18 Mar 2021
Q2 2019 -$16,409,000 01 Apr 2019 30 Jun 2019 10-K 18 Mar 2021
Q1 2019 -$24,019,000 01 Jan 2019 31 Mar 2019 10-K 18 Mar 2021

BIORA THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$124,115,000 -$85,958,000 -2.3% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024
2022 -$38,157,000 +$209,255,000 +84.6% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$247,412,000 -$54,884,000 -28.5% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$192,528,000 -$44,491,000 -30.1% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 -$148,037,000 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.